DS

David Stefany

SA Sanofi: 5 patents #317 of 1,881Top 20%
AP Aventis Pharmaceuticals: 2 patents #139 of 454Top 35%
MI Mars, Incorporated: 1 patents #635 of 1,238Top 55%
Overall (All Time): #601,977 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12302921 Edible ink formulations including calcium carbonate Thomas M. Collins, Kevin J. Stanton 2025-05-20
9533995 Substituted N-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof Zhongli Gao, Daniel Hall 2017-01-03
8859588 Substituted N-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof Zhongli Gao, Daniel Hall 2014-10-14
8796278 Substituted N-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof Zhongli Gao, Daniel Hall 2014-08-05
8383814 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof Zhongli Gao, Ryan Hartung 2013-02-26
8217052 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof Zhongli Gao, Ryan Hartung 2012-07-10
8193183 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists Sungtaek Lim, Keith HARRIS, Charles J. Gardner, Bin Cao, Ray Boffey +4 more 2012-06-05
8173682 Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP) Philip M. Weintraub, Paul Robert Eastwood, Shujaath Mehdi, Kwon Yon Musick, Neil Moorcroft +5 more 2012-05-08